Патрик Холфорд - Скажи НЕТ диабету. Готовый план действий Страница 18

Примечания

1

http://www.diabetes.org.uk/about_us/News_Landing_Page/one-million-people-in-Uk-unaware-they-have-type-2-diabetes/

2

Diabetes Prevalence by age Group, http://www.data360.org/dsg.aspx? Data_Set_Group_id=233

3

International Diabetes Federation, «Global Burden: Projections 2010 and 2030», www.diabetesatlas.org

4

См. http://www.diabetes.org.uk/Professionals/Publications-reports-and-resources/Reportsstatistics-and-case-studies/Reports/Diabetes-prevalence-2010/

5

См. http://www.diabetes.org.uk/Documents/Reports/Diabetes_in_the_Uk_2010.pdf

6

F. B. Hu et al., «Diet, lifestyle, and the risk of type-2 diabetes mellitus in women», New England Journal of Medicine, 2001 Sep; 345: 790–7

7

S. E. Nissen and К. Wolski, «Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes», New England Journal of Medicine, 2007 Jun; 356 (24): 2457–71

8

European Medicines agency, «European Medicines agency recommends suspension of avandia, avandamet and avaglim», press release, 23 Sep 2010

9

Medical News Today, «Part of ACCORD study halted due to safety concerns, Canada», press release, 11 Feb 2008

10

DiabetesinControl.com, «Insulin users have 50 % higher cancer risk: Causes unclear», press release, 2 Sep 2010

11

S. L. Bowker, et al., «Increased Cancer-related mortality for patients with type-2 diabetes who use sulfonylureas or insulin», Diabetes Care, 2006 Feb; 29 (2); 254–8

12

G. Reaven, «Role of insulin resistance in human disease», Diabetes, 1988;37:1595–1607

13

E. Bonora, et al., «Prevalence of insulin resistance in metabolic disorders: the Bruneck Study», Diabetes, 1998 oct; 47 (10): 1643–9

14

T. M. Wallace, et al., «Use and abuse of HOMA modeling», Diabetes Care, 2004;27 (6): 1487–95

15

A. Esteghamati, et al., «Optimal threshold of homeostasis model assessment for insulin resistance in an iranian population: the implication of metabolic syndrome to detect insulin resistance», Diabetes Research and Clinical Practice, 2009 Jun; 84 (3): 279–87; также см. A. Esteghamati, et al., «Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SURFNCD-2007)», Nutrition and Metabolism, 2010 apr 7; 7: 26; see also I. Madeira, et al., «Cut-off point for Homeostatic Model assessment for insulin Resistance (HOMA-IR) index established from Receiver operating Characteristic (ROC) curve in the detection of metabolic syndrome in overweight pre-pubertal children», Arq Bras Endocrinol Metabol, 2008 Dec; 52 (9): 1466–73; также см. Z. Radikova, et al., «Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects», Experimental and Clinical Endocrinology & Diabetes, 2006 May; 114 (5): 249–56; также см. B. Kuwana, et al., «Reference value and cut-off value for diagnosis of insulin resistance in type-2 diabetes mellitus», Rinsho Byori, 2002 apr; 50 (4): 398–403; также см. J. Ascaso, et al., «Insulin resistance quantification by fasting insulin plasma values and HOMA index in a nondiabetic population». Medicina Clinica (Barc), 2001 Nov 3; 117 (14): 530–3

16

E. Selvin, et al., «Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults», New England Journal of Medicine, 2010 Mar 4; 362 (9): 800–11

17

D. Edelman, et al., «Utility of hemoglobin a1c in predicting diabetes risk», Journal of General Internal Medicine, 2004; 19: 1175–80

18

C. L. Rohlfing, et al., «Use of GHb (HbA1c) in Screening for Undiagnosed Diabetes in the U.S. Population», Diabetes Care, 2000; 23: 187–191

19

N. Sarwar, et al., «Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review» Public Library of Science Med, 2010 May 25; 7 (5): e1000278

20

R. M. Krauss, «Carbohydrates raise LDL: atherogenic lipoprotein phenotype and dietgene interactions», Journal of Nutrition, 2001 Feb; 131 (2): 340S-3S

21

E. S. Ford, et al., «Hypertriglyceridemia and its pharmacologic treatment among US Adults», Archives of Internal Medicine, 2009; 169 (6): 572–8

22

E. J. Parks, et al., «Dietary sugars stimulate fatty acid synthesis in adults», Journal of Nutrition, 2008 Jun; 138 (6): 1039–46

23

Dr. W.C. Willett, Symposium on Cancer Prevention, annual meeting of the American association for the advancement of Science, March 2008

24

J. Ahn, et al., «Adiposity, adult weight change, and postmenopausal breast cancer risk», Archives of Internal Medicine, 2007 oct; 167 (19): 2091–102

25

M. J. Gunter, et al., «Insulin, insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women», Journal of the National Cancer Institute, 2009 Jan; 101 (1): 48–60

26

M. Pollak, et al., «Insulin analogues and cancer risk: Cause for concern or cause celebre?», International Journal of Clinical Practice, 2010; 64: 628–36

27

A. Tavani, et al., «Consumption of sweet foods and breast cancer risk in italy», Annals of Oncology, 2006 Feb; 17 (2): 341–5; and C.A. Krone and J.T. Ely, «Controlling hyperglycemia as an adjunct to cancer therapy», Integrative cancer Therapies, 2005 Mar; 4 (1): 25–31; and S.C. Larsson, et al., «Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women», International Journal of Cancer, 2009 July 1; 125 (1): 153–7; and W. Wen, et al., «Dietary carbohydrates, fiber, and breast cancer risk in Chinese women», American Journal of Clinical Nutrition, 2009 Jan.; 89 (1): 283–9; and S. Sieri, et al., «Dietary glycemic index, glycemic load, and the risk of breast cancer in an italian prospective cohort study», American Journal of Clinical Nutrition, 2007 oct.; 86 (4): 1160–6; and M. Lajous, et al., «Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women», American Journal of Clinical Nutrition, 2008 May; 87 (5): 1384–91; and S.E. McCann, et al., «Dietary patterns related to glycemic index and load and risk of premenopausal and postmenopausal breast cancer in the Western New York Exposure and Breast Cancer Study», American Journal of Clinical Nutrition, 2007 aug.; 86 (2): 465–71 170.

28

M.L. Slattery, et al., «Dietary sugar and colon cancer», Cancer Epidemiology, Biomarkers and Prevention, 1997 Sept.; 6 (9): 677–85

29

S.A. Silvera, et al., «Glycaemic index, glycaemic load and ovarian cancer risk: a prospective cohort study», Public Health Nutrition, 2007 oct; 10 (10): 1076–81

30

S.A. Silvera, et al., «Glycaemic index, glycaemic load and risk of endometrial cancer: a prospective cohort study», Public Health Nutrition, 2005 oct; 8 (7): 912–9; and S.C. Larsson, et al., «Carbohydrate intake, glycemic index and glycemic load in relation to risk of endometrial cancer: a prospective study of Swedish women», International Journal of Cancer, 2007 Mar; 120 (5): 1103–7

31

A. Tavani, et al., «Consumption of sweet foods and breast cancer risk in Italy», Annals of Oncology, 2005 oct; 17 (2): 341–5

32

M. Vanhala, et al., «Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study», Acta Psychiatrica Scandinavica, 2009 Feb; 119: 137–142

33

L. Pulkki-Raback, et al., «Depressive Symptoms and the Metabolic Syndrome in Childhood and adulthood: a Prospective Cohort Study», Health Psychology, 2009 Jan; 28 (1): 108–116

34

A. Pan, et al., «Bidirectional association between depression and type-2 diabetes mellitus in women», Archives of Internal Medicine, 2010; 170(21): 1884–91

35

A. Pan, et al., «Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: Findings from the Nutrition and Health of aging Population in China Study», Journal of Affective Disorders, 2008 July; 109 (1): 75–82

36

R. S. McIntyre, et al., «Should depressive syndromes be reclassified as “metabolic syndrome type II”?», Annals of Clinical Psychiatry, 2007 oct – Dec; 19 (4): 257–64

37

H. Viinamäki, et al., «Association of depressive symptoms and metabolic syndrome in men», Acta Psychiatrica Scandinavica, 2009 July; 120 (1): 23–9

38

L. Richardson, et al., «Longitudinal effects of depression on glycemic control in veterans with type-2 diabetes», General Hospital Psychiatry, 2008 Nov; 30 (6): 509–14

39

R. S. McIntyre, et al. «Should depressive syndromes be reclassified as “metabolic syndrome type II”?», Annals of Clinical Psychiatry, 2007 oct – Dec; 19 (4): 257–64

40

T. Matsuzaki, et al., «Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study», Neurology, 2010 aug; 75 (9): 764–70

41

K. Yaffe, «The metabolic syndrome and development of cognitive impairment among older women», Archives of Neurology, 2009 Mar; 66 (3): 324–8

42

A. M. Kanaya, «Total and Regional adiposity and Cognitive Change in older adults: the Health, aging, and Body Composition study», Archives of Neurology 2009 March; 66 (3): 329–335

43

A. Kareinen, et al., «Cardiovascular Risk Factors associated With insulin Resistance Cluster in Families With Early-onset Coronary Heart Disease», Arteriosclerosis Thrombosis and Vascular Biology, 2001; 21; 1346–1352; см. также K. Yaffe, et al., «The Metabolic Syndrome and Development of Cognitive impairment among older Women», Archives of Neurology, 2009; 66 (3): 324–328; см. также S. Craft, «The Role of Metabolic Disorders in alzheimer Disease and Vascular Dementia: two Roads Converged», Archives of Neurology, 2009; 66 (3): 300–305

44

I. Kyrou and C. Tsigos, «Chronic stress, visceral obesity and gonadal dysfunction», Hormones, 2008; 7 (4): 287–293

45

J. Vrbikova, et al., «Metabolic syndrome in adolescents with polycystic ovary syndrome», Gynecological Endocrinology, 2010 Sep; (Только в электронном виде)

46

S. Kayaniyil, et al., «Association of 25 (OH)D and PTH with metabolic syndrome and its traditional and nontraditional components», Journal of Clinical Endocrinology and Metabolism, 2010 oct 27 (Только в электронном виде)

47

A. H. Colagar, et al., «Zinc levels in seminal plasma are associated with sperm quality in fertile and infertile», Nutrition Research, 2009 Feb; 29 (2): 82–88; и M. Akmal, et al., «Improvement in human semen quality after oral supplementation of vitamin C», Journal of Medicinal Food, 2006 Sep; 9 (3):440–2; и A. Khosrowbeygia и N. Zarghami, http://www.plefa.com/article/S0952-3278 %2807 %2900103-2/abstract – aff2, «Fatty acid composition of human spermatozoa and seminal plasma levels of oxidative stress biomarkers in subfertile males», Prostaglandins, Leukotrienes and Essential Fatty Acids, 2007 aug; 77 (2): 117–21

48

S. Hexeberg and F. Lindberg, «Insulin using woman with type-2 diabetes and weight problems», Medisin Og Vitenskap Noe a lare av Tidsskr Nor Legeforen, 2008; 128: 443–5

49

G. Li, et al., «The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study», Lancet, 2008 May; 371 (9626): 1783–9

50

D. R. Jacobs, et al., «Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study», American Journal of Clinical Nutrition, 2009 Feb; 89: 509–17

51

K. J. Copell, et al., «Nutritional intervention in patients with type-2 diabetes who are hyperglycaemic despite optimised drug treatment: Lifestyle over and above Drugs in Diabetes (LOADD) study: Randomised controlled trial», British Medical Journal, 2010 July; 341: c3337 (ISSN: 1468–5833)

52

J. Lindstrom, et al., «The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity», Diabetes Care, 2003; 26 (12): 3230–6

53

W. C. Knowler, «Reduction in the incidence of type-2 diabetes with lifestyle intervention or metformin», New England Journal of Medicine, 2002 Feb 7; 346 (6): 393–403